Literature DB >> 16253593

Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.

Abdul R Halabi1, John H Alexander, Linda K Shaw, Todd J Lorenz, Lawrence Liao, David F Kong, Carmelo A Milano, Robert A Harrington, Peter K Smith.   

Abstract

Up to 20% of saphenous vein grafts (SVGs) fail within 2 years of coronary artery bypass grafting (CABG). The long-term effects of early SVG failure on major clinical events remain undefined in contemporary patient populations. We sought to examine the relation between early SVG failure and long-term outcomes after CABG. Using the Duke Cardiovascular Databank, we examined baseline clinical and angiographic characteristics and clinical outcomes among patients who underwent catheterization 1 to 18 months after their first CABG from 1986 to 2004. Patients were classified on the basis of their worst SVG stenosis as having no (<25%), noncritical (25% to 74%), critical (75% to 99%), or occlusive (100%) SVG disease. Our primary outcome measure was the composite of death, myocardial infarction, or repeat revascularization after catheterization. Of 1,243 patients included in the analysis, 27.9% had no, 11.9% had noncritical, 20.8% had critical, and 39.3% had occlusive SVG disease. At 10 years, the corresponding adjusted composite event rates were 41.2%, 56.2%, 81.2%, and 67.1%, respectively (p <0.0001). Most events occurred immediately after catheterization in patients with critical and occlusive SVG disease and were primarily repeat revascularization. On multivariate analysis, critical, nonocclusive SVG disease was the strongest predictor of the composite outcome (hazard ratio 2.36, 95% confidence interval 2.00 to 2.79, p <0.0001). In conclusion, in contemporary clinical practice, early SVG failure is associated with worse long-term outcomes after CABG.

Entities:  

Mesh:

Year:  2005        PMID: 16253593     DOI: 10.1016/j.amjcard.2005.06.067

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  31 in total

1.  Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.

Authors:  Connie N Hess; Renato D Lopes; C Michael Gibson; Rebecca Hager; Daniel M Wojdyla; Brian R Englum; Michael J Mack; Robert M Califf; Nicholas T Kouchoukos; Eric D Peterson; John H Alexander
Journal:  Circulation       Date:  2014-09-26       Impact factor: 29.690

2.  Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function.

Authors:  Susan Eagle; Colleen M Brophy; Padmini Komalavilas; Kyle Hocking; Gowthami Putumbaka; Michael Osgood; Kevin Sexton; Marzia Leacche; Joyce Cheung-Flynn
Journal:  Am Surg       Date:  2011-07       Impact factor: 0.688

3.  Pre-operative use of aspirin in patients undergoing coronary artery bypass grafting: a systematic review and updated meta-analysis.

Authors:  Karla Solo; Shahar Lavi; Tawfiq Choudhury; Janet Martin; Immaculate F Nevis; Chun Shing Kwok; Rafail A Kotronias; Natsumi Nishina; Sandro Sponga; Diana Ayan; Nikolaos Tzemos; Mamas A Mamas; Rodrigo Bagur
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.

Authors:  Tyler J Gluckman; Rhondalyn C McLean; Steven P Schulman; Thomas S Kickler; Edward P Shapiro; John V Conte; Kathleen W McNicholas; Jodi B Segal; Jeffrey J Rade
Journal:  J Am Coll Cardiol       Date:  2011-03-01       Impact factor: 24.094

5.  Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery.

Authors:  R C McLean; S M Nazarian; T J Gluckman; S P Schulman; D R Thiemann; E P Shapiro; J V Conte; J B Thompson; I Shafique; K W McNicholas; T C Villines; K M Laws; J J Rade
Journal:  J Cardiovasc Surg (Torino)       Date:  2011-12       Impact factor: 1.888

6.  Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study.

Authors:  Jack C J Sun; Kevin H T Teoh; Tej Sheth; David Landry; Hyejung Jung; Theodore E Warkentin; Salim Yusuf; Andre Lamy; John W Eikelboom
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

7.  Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery?

Authors:  Ralf E Harskamp; Judson B Williams; Ronald C Hill; Robbert J de Winter; John H Alexander; Renato D Lopes
Journal:  Am Heart J       Date:  2013-03-07       Impact factor: 4.749

Review 8.  Coronary vein graft disease: pathogenesis and prevention.

Authors:  Pirouz Parang; Rohit Arora
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

9.  Patient-Specific Simulations Reveal Significant Differences in Mechanical Stimuli in Venous and Arterial Coronary Grafts.

Authors:  Abhay B Ramachandra; Andrew M Kahn; Alison L Marsden
Journal:  J Cardiovasc Transl Res       Date:  2016-07-22       Impact factor: 4.132

10.  Association between Plasma Fibrinogen Level and Saphenous Vein Graft Patency.

Authors:  Sinan Cersit; Serkan Cay; Yavuzer Koza; Sadik Kadri Acikgoz; Gizem Cabuk; Bihter Senturk; Pinar Dogan
Journal:  Acta Cardiol Sin       Date:  2014-05       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.